COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.

Parikshit Sen Naveen R Albert Selva-O'Callaghan James B Lilleker Vishwesh Agarwal Sinan Kardeş Minchul Kim Jessica A Day Marcin Milchert Tamer A Gheita Babur Salim Tsvetelina V Velikova Abraham Edgar Gracia-Ramos Ioannis Parodis Albert Selva O'Callaghan Elena Nikiphorou Tulika Chatterjee Ai Lyn Tan Lorenzo Cavagna Miguel Ángel Saavedra-Salinas Samuel Katsuyuki Shinjo Nelly Ziadé Johannes Knitza Masataka Kuwana Oliver Distler Gabriela Arredondo Hector Chinoy Vikas Agarwal Rohit Aggarwal Latika Guptanull null

Published in: Rheumatology (Oxford, England) (2022)

Vaccination against COVID-19 is relatively safe in SAID patients. SAIDs were at a higher risk of major ADEs than HCs, though absolute risk was small. There are small differences in minor ADEs between vaccine types in SAID patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
coronavirus disease
peritoneal dialysis
sars cov
prognostic factors
multiple sclerosis
patient reported outcomes
respiratory syndrome coronavirus